Asthma Trial, Recruiting NCT06116292 Sponsor: Hospital Universitari de Bellvitge Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT06116292
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have been diagnosed with asthma according to specific medical guidelines (GEMA 5.2 2022) (confirm with trial site)
  • You are a patient being seen in the lung/breathing department (pulmonology service) at the trial centre
  • You have never received any formal education or training about managing your asthma before
  • You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

  • You do not own or have access to a smartphone that runs Android or Apple (iOS) software
  • You do not have basic enough experience using apps on a smartphone to use the study's app (called ESTOI)
  • You are currently taking part in, or have taken part in, another clinical trial within the last 6 months
  • You have been diagnosed with another lung or breathing condition, other than obstructive sleep apnea (a condition where breathing stops briefly during sleep) or a combination of asthma and a condition called COPD (confirm with trial site)
  • You have a serious long-term illness or are receiving end-of-life (palliative) care that affects your life expectancy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Héctor Cabrerizo Carreño, M.N, Hospital Universitari de Bellvitge

Phone: +34 677281333

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Universitari de Bellvitge
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Asthma Control Test (ACT); Number of exacerbations; Peak Expiratory Flow (PEF); Forced expiratory volume in one second (FEV1)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov